Stay updated with breaking news from Pharmaceutical Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine. Two people in their 60s who received
A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her
/PRNewswire/ -- The "Latest Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation)" training has been added to...
Following a rigorous application process, we are proud to announce that Seda have been selected as the UK Life Sciences Innovator Winner 2023 in the Application, Product & Service Design Category.
NORTHAMPTON, MA / ACCESSWIRE / February 15, 2023 / Innovation is at the core of Gilead's 35-year history of life-changing medicines. Through bold and transformative science, Gilead has developed therapies